Revolutionary molecule improves potency of skincare regimen for hyperpigmentation disorders

A sponsored symposium by La Roche-Posay saw two leading experts discuss hyperpigmentation disorders in terms of its global impact on patients and social stigma, and the use of an innovative molecule, Melasyl TM, to treat patients. A serum containing Melasyl TM was launched during the symposium.